jnj 10181457 profile

ID Source	ID
PubMed CID	9944610
CHEMBL ID	237087
SCHEMBL ID	3902790
MeSH ID	M0504641

Synonym
CHEMBL237087 ,
4-[3-(4-piperidin-1-yl-but-1-ynyl)-benzyl]-morpholine
bdbm50217569
4-(3-(4-(piperidin-1-yl)but-1-ynyl)benzyl)morpholine
morpholine, 4-((3-(4-(1-piperidinyl)-1-butynyl)phenyl)methyl)-
jd270971qc ,
jnj-10181457
544707-19-9
morpholine, 4-((3-(4-(1-piperidinyl)-1-butyn-1-yl)phenyl)methyl)-
4-(3-(4-(piperidinyl)but-1-ynyl)benzyl)morpholine
unii-jd270971qc
1188547-18-3
SCHEMBL3902790
NCGC00371051-01
AKOS032947030
jnj10181457
4-[3-[4-[piperidinyl]but-1-ynyl]benzyl]morpholinedihydrochloride
Q27281445
4-[[3-(4-piperidin-1-ylbut-1-ynyl)phenyl]methyl]morpholine
HY-107562A
CS-0083501

Excerpt	Reference	Relevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."	( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019)	0.51

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
cytochrome P450 2D6	Homo sapiens (human)	Potency	26.8370	0.0010	8.3798	61.1304	AID1645840
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Histamine H1 receptor	Homo sapiens (human)	Ki	10.0000	0.0000	0.5110	10.0000	AID436618
Histamine H4 receptor	Homo sapiens (human)	Ki	10.0000	0.0006	0.4787	10.0000	AID436619
Histamine H3 receptor	Rattus norvegicus (Norway rat)	Ki	0.0071	0.0001	0.2963	8.5110	AID436617
Histamine H3 receptor	Homo sapiens (human)	Ki	0.0011	0.0001	0.3399	8.5110	AID300627; AID436615; AID526118; AID599203
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Histamine H3 receptor	Rattus norvegicus (Norway rat)	Kd	0.0047	0.0047	0.0047	0.0047	AID436631
Histamine H3 receptor	Homo sapiens (human)	Kd	0.0005	0.0001	0.0138	0.0631	AID436630; AID599205
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
inflammatory response	Histamine H1 receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Histamine H1 receptor	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	Histamine H1 receptor	Homo sapiens (human)
memory	Histamine H1 receptor	Homo sapiens (human)
visual learning	Histamine H1 receptor	Homo sapiens (human)
regulation of vascular permeability	Histamine H1 receptor	Homo sapiens (human)
positive regulation of vasoconstriction	Histamine H1 receptor	Homo sapiens (human)
regulation of synaptic plasticity	Histamine H1 receptor	Homo sapiens (human)
cellular response to histamine	Histamine H1 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Histamine H1 receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Histamine H1 receptor	Homo sapiens (human)
chemical synaptic transmission	Histamine H1 receptor	Homo sapiens (human)
inflammatory response	Histamine H4 receptor	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Histamine H4 receptor	Homo sapiens (human)
biological_process	Histamine H4 receptor	Homo sapiens (human)
regulation of MAPK cascade	Histamine H4 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Histamine H4 receptor	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	Histamine H4 receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Histamine H4 receptor	Homo sapiens (human)
chemical synaptic transmission	Histamine H4 receptor	Homo sapiens (human)
neurotransmitter secretion	Histamine H3 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Histamine H3 receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Histamine H3 receptor	Homo sapiens (human)
chemical synaptic transmission	Histamine H3 receptor	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	Histamine H3 receptor	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
histamine receptor activity	Histamine H1 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Histamine H1 receptor	Homo sapiens (human)
neurotransmitter receptor activity	Histamine H1 receptor	Homo sapiens (human)
histamine receptor activity	Histamine H4 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Histamine H4 receptor	Homo sapiens (human)
G protein-coupled acetylcholine receptor activity	Histamine H4 receptor	Homo sapiens (human)
histamine receptor activity	Histamine H3 receptor	Homo sapiens (human)
G protein-coupled acetylcholine receptor activity	Histamine H3 receptor	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Histamine H3 receptor	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
cytosol	Histamine H1 receptor	Homo sapiens (human)
plasma membrane	Histamine H1 receptor	Homo sapiens (human)
synapse	Histamine H1 receptor	Homo sapiens (human)
dendrite	Histamine H1 receptor	Homo sapiens (human)
plasma membrane	Histamine H1 receptor	Homo sapiens (human)
plasma membrane	Histamine H4 receptor	Homo sapiens (human)
plasma membrane	Histamine H4 receptor	Homo sapiens (human)
dendrite	Histamine H4 receptor	Homo sapiens (human)
synapse	Histamine H4 receptor	Homo sapiens (human)
plasma membrane	Histamine H3 receptor	Homo sapiens (human)
presynapse	Histamine H3 receptor	Homo sapiens (human)
plasma membrane	Histamine H3 receptor	Homo sapiens (human)
synapse	Histamine H3 receptor	Homo sapiens (human)
dendrite	Histamine H3 receptor	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (28)

Assay ID	Title	Year	Journal	Article
AID436617	Displacement of [3H]N-alpha-methylhistamine from rat histamine H3 receptor expressed in SK-N-MC cells	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436619	Displacement of [3H]N-alpha-methylhistamine from histamine H4 receptor expressed in SK-N-MC cells	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436632	Wake promoting activity in Sprague-Dawley rat assessed as effect on rapid eye movement sleep at 10 mg/kg, sc	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436620	Inhibition of human ERG at 10 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID300627	Binding affinity to human histamine H3 receptor	2007	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 17, Issue:17	Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
AID599203	Displacement of [3H]N-alpha-methylhistamine from human histamine H3 receptor expressed in SK-N-MC cells	2009	European journal of medicinal chemistry, Nov, Volume: 44, Issue:11	Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.
AID436630	Antagonist activity at human histamine H3 receptor expressed in SK-N-MC cells assessed as inhibition of forskolin-stimulated cAMP accumulation treated 10 min before histamine challenge	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID526118	Displacement of [125I]iodoproxyfan from human recombinant histamine H3 receptor expressed in human SK-N-MC cells after 1 hr by fluid scintillation counting	2010	Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21	Indole- and benzothiophene-based histamine H3 antagonists.
AID436629	Oral bioavailability in rat	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436633	Half life in po dosed rat	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436628	Plasma protein binding in human	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436621	Inhibition of human ERG at 3 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436618	Displacement of [3H]N-alpha-methylhistamine from histamine H1 receptor expressed in SK-N-MC cells	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436631	Antagonist activity at rat H3 receptor expressed in SK-N-MC cells assessed as inhibition of forskolin-stimulated cAMP accumulation treated 10 min before histamine challenge	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436622	Inhibition of CPY1A2 at >40 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436615	Displacement of [3H]N-alpha-methylhistamine from human histamine H3 receptor expressed in SK-N-MC cells	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436625	Inhibition of CPY2C19 at >40 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436616	Ex vivo histamine H3 receptor occupancy in rat striatum at 30 mg/kg, po after 1 hr	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436623	Inhibition of CPY2C9 at >40 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436624	Wake promoting activity in Sprague-Dawley rat assessed as decrease in non-rapid eye movement sleep at 10 mg/kg, sc	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID599205	Antagonist activity at human histamine H3 receptor expressed in SK-N-MC cells assessed as inhibition of forskolin stimulated cAMP accumulation after 6 hrs	2009	European journal of medicinal chemistry, Nov, Volume: 44, Issue:11	Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.
AID436626	Inhibition of CPY2D6 at >40 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID436627	Inhibition of CPY3A4 at >40 uM	2009	European journal of medicinal chemistry, Oct, Volume: 44, Issue:10	Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
AID1346987	P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986	P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008	Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening	2020	SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159	Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160	Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	2 (28.57)	24.3611
2020's	2 (28.57)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	7 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
fluoxetine Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.. fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.. N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.	2.03	1	(trifluoromethyl)benzenes; aromatic ether; secondary amino compound
alpha-methylhistamine (R)-alpha-methylhistamine : An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position (the R-enantiomer).	2.05	1	aralkylamino compound; imidazoles	H3-receptor agonist
interferon-gamma aplysamine-1: from sponge Aplysia sp.; structure in first source	2.05	1
jnj-5207852 [no description available]	2.74	3
thioperamide thioperamide: structure given in first source; histamine H3 receptor antagonist	2.45	2	primary aliphatic amine
nnc 38-1049 NNC 38-1049: selective histamine H3 receptor antagonist; structure in first source	2.05	1
benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- [no description available]	2.05	1
pitolisant pitolisant: functions as both inverse agonist and antagonist of histamine H3 receptors; structure in first source	2.05	1	organochlorine compound

Condition	Relationship Strength	Studies
Congenital Zika Syndrome [description not available]	2.25	1
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.	2.25	1
Zika Virus Infection A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.	2.25	1

jnj 10181457

Cross-References

Synonyms (21)

Research Excerpts

Bioavailability

Protein Targets (5)

Potency Measurements

Inhibition Measurements

Activation Measurements

Biological Processes (17)

Molecular Functions (4)

Ceullar Components (5)

Bioassays (28)

Research

Studies (7)

Market Indicators

Research Demand Index: 12.36

Study Types

jnj 10181457

Cross-References

Synonyms (21)

Research Excerpts

Bioavailability

Protein Targets (5)

Potency Measurements

Inhibition Measurements

Activation Measurements

Biological Processes (17)

Molecular Functions (4)

Ceullar Components (5)

Bioassays (28)

Research

Studies (7)

Market Indicators

Research Demand Index: 12.36

Study Types

Related Drugs (8)

Related Conditions (3)